E Fund Management (Hong Kong) Co., Ltd.

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1777469 CENTRAL, K3

Position in VRTX

as of Jun 30, 2026 · filed Jul 22, 2026 Compact

Position Value

$736,650

+$331,639 QoQ

Shares Held

1,483

+63.5% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.29%

of 13F equity value

Holder Rank

#937

of 1,730 holders

Holding Since

Sep 2022

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

E Fund Management (Hong Kong) Co., Ltd. holds $3,346,723 across 45 Biotechnology names. VRTX ranks #2 (22.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LEGN	Legend Biotech Corp	28,209	$814,675
2	VRTX	Vertex Pharmaceuticals Inc / Ma This page	1,483	$736,650
3	REGN	Regeneron Pharmaceuticals, Inc.	621	$387,218
4	ALNY	Alnylam Pharmaceuticals, Inc.	778	$234,201
5	MRNA	Moderna, Inc.	3,249	$227,527
6	RVMD	Revolution Medicines, Inc.	207	$38,766
7	TGTX	Tg Therapeutics, Inc.	691	$37,963
8	AXSM	Axsome Therapeutics, Inc.	128	$31,330

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$736,650	1,483	+63.5%	Shares	Sole	2026-07-22
2026-03-31	$405,011	907	+5.5%	Shares	Sole	2026-04-08
2025-12-31	$389,889	860	+252.5%	Shares	Sole	2026-02-05
2025-09-30	$95,560	244	+103.3%	Shares	Sole	2025-10-23
2025-06-30	$53,424	120	0.0%	Shares	Sole	2025-07-24
2025-03-31	$58,178	120	+471.4%	Shares	Sole	2025-04-23
2024-12-31	$8,456	21	+425.0%	Shares	Sole	2025-01-22
2024-09-30	$1,860	4	0.0%	Shares	Sole	2024-10-28
2024-06-30	$1,874	4	-99.9%	Shares	Sole	2024-07-12
2022-09-30	$1,882,010	6,500	—	Shares	Sole	2022-10-24
No filing history on record for this holder in this stock.